(2021) demonstrated that the Wnt/β-catenin signaling pathway inhibitor ICG-001, when used in conjunction with radiotherapy, enhances the DNA damage response and increases the radiosensitivity of HCC by inhibiting the activation of the p53-mediated cGAS-STING pathway (157). This evidence concerns the gene CGAS and hepatocellular carcinoma.